Suzanne Weber, MD
Obstetrics & Gynecology · Littleton, CONPI 1003914599
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $15,453 of the $17,568 with a category attached, or 88.0%. Astellas Pharma US Inc accounts for 92.0% of it on its own, with 23 other manufacturers making up the rest. Reporting peaked in 2023 at $8,245 and has fallen 74.2% since, to $2,125 in 2025. Among obstetrics & gynecology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 90 payments — averaging $195.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$16K
- Bayer$251
- Baxter Healthcare$153
- Mayne Pharma Commercial LLC$133
- AbbVie$101
- Pfizer$86
- plus $680 from 18 others
What the payments were for
- Consulting fees$500%
- Speaking & faculty fees$15,45388%
- Travel & lodging$1331%
- Food & beverage$1,90111%
- Education$320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 17 | $16,165 |
| Bayer | 13 | $251 |
| Baxter Healthcare | 2 | $153 |
| Mayne Pharma Commercial LLC | 2 | $133 |
| AbbVie(2 entities) | 6 | $101 |
| Pfizer | 6 | $86 |
| Hologic Sales And Service, LLC | 4 | $82 |
| Exeltis, USA Inc. | 5 | $74 |
| Organon | 5 | $71 |
| Avion Pharmaceuticals | 4 | $59 |
| Myovant Sciences Inc. | 3 | $49 |
| Agile Therapeutics, Inc. | 3 | $42 |
| Evofem Biosciences, Inc. | 3 | $42 |
| Therapeuticsmd, Inc. | 3 | $40 |
| Medicem Inc. | 1 | $34 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Coopersurgical, Inc. | 2 | $30 |
| Merck | 2 | $30 |
| Coloplast | 2 | $26 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Roche Diagnostics Corporation | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
| Lupin Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Veozah$15,451
- FLOSEAL$122
- TISSEEL$122
- NEXTSTELLIS$121
How this compares
$17,568 in reported general payments places this provider in the 95th percentile of 705 obstetrics & gynecology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 80 | $8,853 |
| Estradiol (Twice Weekly)Estradiol | 41 | $5,277 |
| IntrarosaPrasterone (Dhea) | 15 | $4,579 |
| ProgesteroneProgesterone, Micronized | 23 | $1,364 |
| Clobetasol Propionate | 25 | $930 |
| YuvafemEstradiol | 11 | $857 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AMAG Pharmaceuticals, Inc.Intrarosa | $14 | $4,57915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 705 obstetrics & gynecology providers in Colorado.
Other obstetrics & gynecology in Littleton
- Emily LandersLittleton$28K
- Julie GelmanLittleton$27K
- Rayna TrietschLittleton$6K
- John CraneLoveland$415K
- James LukbanEnglewood$175K
- Wayne FurrLonetree$106K
- William BrownDenver$76K
- Kristina TocceDenver$57K
- Jill LissAurora$57K
- Alison CowanLouisville$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.